Chittorgarh.com Logo
Loading...

Sudarshan Pharma Industries Limited IPO (Sudarshan Pharma IPO) Detail

Jun 12, 2019 - Jun 21, 2019

Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.

The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.

The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.

The competitive strengths of the company are:

1. Customer-centric and order driven business model
2. Wide range of product offerings
3. Contract manufacturing facility arrangements
4. Strong distribution, marketing and sales network
5. Diversified business operations

Company Promoters:

Mr. Hemal V. Mehta and Mr. Sachin V. Mehta are the promoters of the company.

Company Financials:

Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lakhs)
31-Mar-19 31-Mar-18 31-Mar-17 31-Mar-16
Total Assets 5,013.72 3,096.37 1,992.93 827.24
Total Revenue 14,001.96 8,976.43 5,551.72 3,794.33
Profit After Tax 234.79 73.98 15.63 9.27

Objects of the Issue:

The Net Proceeds from the Issue are proposed to be utilized by the Company for the following objects:

1) To set up a dedicated manufacturing facility for Pharmaceutical Business;
2) Distribution and Warehousing Centre's & Purchase of Corporate Office;
3) Additional Working Capital;
4) General Corporate Expenses; and
5) To meet the expenses of the Issue.

Sudarshan Pharma IPO Details

IPO Opening Date Jun 12, 2019
IPO Closing Date Jun 21, 2019
Issue Type Fixed Price Issue IPO
Face Value ₹10 per equity share
IPO Price ₹72 per equity share
Market Lot 1600 Shares
Min Order Quantity 1600 Shares
Listing At NSE SME
Issue Size3,440,000 Eq Shares of ₹10
(aggregating up to ₹24.77 Cr)

Sudarshan Pharma IPO Tentative Timetable

The Sudarshan Pharma IPO open date is Jun 12, 2019, and the close date is Jun 21, 2019. The issue may list on Jun 25, 2019.

IPO Open Date Jun 12, 2019
IPO Close Date Jun 21, 2019
Basis of Allotment Date Jun 20, 2019
Initiation of Refunds Jun 21, 2019
Credit of Shares to Demat Account Jun 24, 2019
IPO Listing Date Jun 25, 2019

Sudarshan Pharma IPO Lot Size

The Sudarshan Pharma IPO market lot size is 1600 shares. A retail-individual investor can apply for up to 1 lots (1600 shares or ₹115,200).

Application Lots Shares Amount (Cut-off)
Minimum 1 1600 ₹115,200
Maximum 1 1600 ₹115,200

Sudarshan Pharma IPO Promoter Holding

Pre Issue Share Holding 89.29%
Post Issue Share Holding 65.63%

IPO Notices

External Link

Withdrawal of initial public offer by Sudarshan Pharma Industries Limited

Date: 24 June 2019

The Company has decided to withdraw the application made for SME IPO on NSE Platform due to material changes in the current business model and future expansion plan. The entire application money will be refunded forthwith.

Sudarshan Pharma IPO Subscription Status (Bidding Detail)

The Sudarshan Pharma IPO is subscribed 0.47 times on Jun 21, 2019 18:00. The public issue subscribed 0.77 in the retail category, in the QIB category, and 0.17 in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)
NII

0.17

RII

0.77

Total

0.47

Sudarshan Pharma IPO Prospectus

Sudarshan Pharma IPO Rating

112
3.6
Rating:Rated 3.6 stars
Vote Here ...

Company Contact Information

Sudarshan Pharma Industries Limited
301, 3rd Floor, Aura Biplex,
Above Kalyan Jewellers, S V Road,
Borivali (West), Mumbai - 400 092,
Phone: +91 22 242221111
Email: compliance.spil@gmail.com
Website: http://www.sudarshanpharma.com/

Sudarshan Pharma IPO Registrar

KFintech Private Limited

Phone: 04067162222, 04079611000
Email: einward.ris@karvy.com
Website: https://karisma.kfintech.com/

Sudarshan Pharma IPO Reviews / Ratings

Sudarshan Pharma IPO FAQs

Sudarshan Pharma IPO is a SME IPO of 3,440,000 equity shares of the face value of ₹10 aggregating up to ₹24.77 Crores. The issue is priced at ₹72 per equity share. The minimum order quantity is 1600 Shares.

The IPO opens on Jun 12, 2019, and closes on Jun 21, 2019.

KFintech Private Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

The Sudarshan Pharma IPO opens on Jun 12, 2019 and closes on Jun 21, 2019.

Sudarshan Pharma IPO lot size is 1600 Shares and the minimum order quantity is 1600 Shares.

You can apply in Sudarshan Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Sudarshan Pharma IPO will be done on Jun 20, 2019, and the allotted shares will be credited to your demat account by Jun 24, 2019. Check the Sudarshan Pharma IPO allotment status.

The Sudarshan Pharma IPO listing date is not yet announced. The tentative date of Sudarshan Pharma IPO listing is Jun 25, 2019.

Sudarshan Pharma IPO Message Board

Ranked Members  Ranked Members

Loading...
40. MR. KUMAR |Jun 23, 2019 13:58
Thumb rule of making more money in ipo is one and only subscriptions .If overall subscriptions is more than 20 times then 100 percent good listing gain happens whether company is good or bad. e.g - E2E NETWORK, MAHICKRA, DANGEE DUMS, D P ABHUSHAN .So if subscriptions is less then 20 times then there will be a big risk.
39. Satishsg |Jun 18, 2019 18:34
Sudarshan Pharma is into the Forward Integration from chemical to Finished Formulation and the company is growing up so fast, also I had visited Sudarshan Pharma official website so I suggest to purchased IPO LOTS.
39.1. papon |Jun 20, 2019 10:27
Top Contributor Top Contributor (300+ Posts, 300+ Likes)
Company has so much demand for their products but no demand for their shares. So ipo need to be extended. So sad
39.2. MR. KUMAR |Jun 22, 2019 12:58
Who are you to suggested?? Are you a researcher???
38. Purvi Lakhani |Jun 18, 2019 18:56
Sudarshan pharma is fastest growing company (as per profit and Revenue) hence I suggest to everyone for subscription of Sudarshan pharma IPO.
38.4. MR. KUMAR |Jun 20, 2019 11:25
This is your first post , are you a company promoters???
38.5. Small Investor |Jun 21, 2019 11:09
IPO Guru IPO Guru (1500+ Posts, 800+ Likes)
# Purvi your Company IPO is Flop Show
37. Shivani dubey |Jun 21, 2019 07:36
If everything seems under control, you are not going fast enough.... Let the people take their call.... Champions keep playing until they get it right..... If you can't say good,dont say bad...
36. Sunil Shivaji Murkute |Jun 18, 2019 17:38
Company product are good and company customer base is strong, products drive is the company and customer loyalty key to success,so I have purchase few lots.
36.1. papon |Jun 20, 2019 10:16
Top Contributor Top Contributor (300+ Posts, 300+ Likes)
Many company agents bids got rejected in earlier issues. Kindly check if your bid is ok or else you will not get allotment & you will be in depression
35. MR. KUMAR |Jun 19, 2019 15:55
Avoid all sme and invest your money in mutual funds and get 20 percent return.
34. MR. KUMAR |Jun 19, 2019 15:53
See the conditions of Par drugs.
33. MR. KUMAR |Jun 19, 2019 15:52
Don't apply in Sudarshan pharma. It's fair price is RS 40 .So if you apply you will be in heavy loss.
32. Small Investor |Jun 19, 2019 10:54
IPO Guru IPO Guru (1500+ Posts, 800+ Likes)
There are Company's Agent coming to promote Company
keep away
31. Dilip Davda |Jun 17, 2019 20:21
Due to heavy under subscription, Issue stands extended till 24th June 2019. Company has also reduced the price to Rs. 72 per share from Rs. 75 per share, still valuation is very much on the higher side. My conclusion remains the same despite price reduction. - Simply Avoid.

Dilip Davda
SEBI registered Research Analyst
Mumbai

Read my IPO Reviews

30. GrowYourMoney |Jun 17, 2019 17:01
Top Contributor Top Contributor (300+ Posts, 300+ Likes)
extended till 24th June
29. GrowYourMoney |Jun 17, 2019 15:52
Top Contributor Top Contributor (300+ Posts, 300+ Likes)
10 Mins to go (HNI Subscription)

still

0.42X

seems extension or withdrawal on cards


28. GrowYourMoney |Jun 17, 2019 15:34
Top Contributor Top Contributor (300+ Posts, 300+ Likes)
some guys were very positive on this co

but it seems

they haven't invested

still under subscribed (HNI few min away)
27. KING VINOD |Jun 17, 2019 15:20
IPO Guru IPO Guru (1400+ Posts, 3000+ Likes)
Clearly Avoid
26. Hiteshji |Jun 16, 2019 14:46
Top Contributor Top Contributor (400+ Posts, 200+ Likes)
Completely avoid sme now days. Look for better company and batter valuations.
25. Aviralguptak |Jun 15, 2019 18:34
They priced in 55 rs but later they changed to 75 rs.look at greed of merchant banker.lets skip it completely
At least other issue like Evans gk
Price at very low pe. They are pricing at even higher than its big company in main board. Shame
24. Aviralguptak |Jun 15, 2019 10:41
First overseas last 15 issues almost 11 issues are down between 50 to 80 pc of issue price. Retailer please save your money. Please donate to orphanage rather than giving money to these lootera LM and such overvaluated asking greedy LM and companies. Request you to check the greed of the company and merchant banker asking for 40 pe. Please save unheard earn money and don't fall in their trap of a0plication applied and will be withdrawn on last day
24.1. Small Investor |Jun 15, 2019 11:38
IPO Guru IPO Guru (1500+ Posts, 800+ Likes)
Promoters rs 10 ka shares 75 m sell kr rha ,vese LM bhi kisi kam ka nhi h,mostly stock are trading in huge discount and few only above issue price jo risk leta ho wo isme Apply kr sakta h and but i do't risk i skip this
avoid avoid
23. Aviralguptak |Jun 15, 2019 08:48
Please do not apply
There are Farzi bids made by company and its employee and relative which will be cancelled at last day
Please save your hard earn money. It has come up with very high price and first overseas its Im is anyway lootera. It priced first at 55 rs and then increased to 75. It does not deserve price of more than 40 rs
Coming up with 30 crore issue with 40 pe is anyway crime. Don't let these lootera take away your money
22. Aviralguptak |Jun 15, 2019 01:56
Instead of applying in these companies let us all those in this group float a company and come with our own lpo sme. It is a guarantee money return which we all can share with no risk at all
This is what govt/exchange are doing giving hard earn money of innocent retailer to these companies. There should always been some control of exchange to get quality s rips only rather than anyone can come. Let us all join hands not to apply in any new issues. We should all come up with our own loo which is very easy nowdays
21. Sundaram Badholiya |Jun 14, 2019 03:21
Wanna buy some shares.